2019 annual financial data

Neuphoria Therapeutics 2019 Operating margin

Direct answer

Operating margin was -145.46%.

Operating income was -10.76M USD and net income was -6.77M USD.
Operating cash flow was -10.91M USD.

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7.4M USD
Operating income
-10.76M USD
Net income
-6.77M USD
Operating cash flow
-10.91M USD